Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
32 hedge funds and large institutions have $86.3K invested in Ampio Pharmaceuticals Inc. in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 69 closing their positions.
6,300% more call options, than puts
Call options by funds: $192K | Put options by funds: $3K
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
66% less funds holding
Funds holding: 95 → 32 (-63)
90% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 69
95% less capital invested
Capital invested by funds: $1.77M → $86.3K (-$1.68M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19K |
| 2 |
HF
HRT Financial
New York
|
+$4.15K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.67K |
| 4 |
ARG
Advisory Resource Group
Tulsa,
Oklahoma
|
+$3.23K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$602K |
| 2 |
BlackRock
New York
|
-$281K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$99K |
| 4 |
PCMC
Private Capital Management (Colorado)
Denver,
Colorado
|
-$57K |
| 5 |
SA
Shilanski & Associates
Anchorage,
Alaska
|
-$57K |
AMPE Hedge Fund Activity: Q4 2022 in Review
32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2022, worth a combined $86.3K — down 95% from $1.77M a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of AMPE and 7 opened new positions — a net loss of 62 holders — while 8 trimmed existing stakes and 8 added.
The largest buyer was Susquehanna International Group, adding an estimated $19K. The largest seller was Vanguard Group, exiting entirely with an estimated $602K sold.
- 32 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2022, down from 95 in Q3 2022.
- Funds reported $86.3K of Ampio Pharmaceuticals Inc. stock for Q4 2022, down 95% quarter-over-quarter.
- 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2022 and 69 closed out, a net change of -62 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2022 was Susquehanna International Group, an estimated $19K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2022 was Vanguard Group, an estimated $602K sold.
Based on aggregated 13F filings for Q4 2022.